What are the limitations of the lugano classification?

While the lugano classification is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the lugano classification to ensure safe bedside use and optimal diagnostic accuracy.

How does the lugano classification compare to other Oncology scores?

The lugano classification is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the lugano classification free to use?

Yes. OpiCalc provides the lugano classification completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

Lugano Classification

Lymphoma

PET-CT aligned staging framework for lymphoma.

Single nodal region or single extranodal site

Multiple nodal regions on one side of diaphragm

Nodal disease on both sides of diaphragm

Contiguous extranodal extension

Diffuse/disseminated extranodal involvement

Calculated Interpretation

Stage I

Lugano staging is anchored on nodal distribution, contiguous extranodal spread, and diffuse extranodal disease.

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

Primary Use

PET-CT aligned staging framework for lymphoma.

CLINICAL INSIGHT

How it Works

Clinical Inputs

Single nodal region or single extranodal site

Multiple nodal regions on one side of diaphragm

Nodal disease on both sides of diaphragm

Contiguous extranodal extension

Diffuse/disseminated extranodal involvement

CLINICAL INSIGHT

Practical Pearls

Result Bands

CLINICAL INSIGHT

Next Steps

Suggested Next Steps

Interpret the result in the full disease-specific clinical context.
Correlate with pathology, imaging, performance status, and multidisciplinary guidance.

CLINICAL INSIGHT

Evidence Base

PET-CT aligned staging framework for lymphoma.

OpiCalc Medical Oncology ModuleLymphoma2026

CLINICAL INSIGHT

Background

Context

Lugano Classification is included in the oncology module as a structured decision-support tool for lymphoma workflows.

No clinical reference data available.

Lugano Classification

Lymphoma

PET-CT aligned staging framework for lymphoma.

Single nodal region or single extranodal site

Multiple nodal regions on one side of diaphragm

Nodal disease on both sides of diaphragm

Contiguous extranodal extension

Diffuse/disseminated extranodal involvement

Calculated Interpretation

Stage I

Lugano staging is anchored on nodal distribution, contiguous extranodal spread, and diffuse extranodal disease.

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

Primary Use

PET-CT aligned staging framework for lymphoma.

CLINICAL INSIGHT

How it Works

Clinical Inputs

Single nodal region or single extranodal site

Multiple nodal regions on one side of diaphragm

Nodal disease on both sides of diaphragm

Contiguous extranodal extension

Diffuse/disseminated extranodal involvement

CLINICAL INSIGHT

Practical Pearls

Result Bands

CLINICAL INSIGHT

Next Steps

Suggested Next Steps

Interpret the result in the full disease-specific clinical context.
Correlate with pathology, imaging, performance status, and multidisciplinary guidance.

CLINICAL INSIGHT

Evidence Base

PET-CT aligned staging framework for lymphoma.

OpiCalc Medical Oncology ModuleLymphoma2026

CLINICAL INSIGHT

Background

Context

Lugano Classification is included in the oncology module as a structured decision-support tool for lymphoma workflows.

No clinical reference data available.